Literature DB >> 1420840

Sequential monitoring for comparison of changes in a response variable in clinical studies.

M C Wu1, K K Lan.   

Abstract

The spending function approach proposed by Lan and DeMets (1983, Biometrika 70, 659-663) for sequential monitoring of clinical trials is applied to situations where comparison of changes in a continuous response variable between two groups is the primary concern. Death, loss to follow-up, and missed visits could cause follow-up measurements to be right-censored or missing for some participants. Furthermore, the probability of being censored may be dependent on the parameter value of the response variable (informative censoring). We propose to compare treatment effects by comparing areas under the expected response change curves between the two groups. When the response curves are linear as a function of time in both groups, this comparison is equivalent to comparing the rates of change in the response variable. Covariances of the sequential test statistics are derived. Conditions for having independent increments are presented. For studies designed to evaluate long-term treatment effects, spending functions obtained by shifting the usual spending functions (Kim and DeMets, 1987, Biometrika 74, 149-154) to the right and then rescaling to the remaining interval are also proposed. Such a shifted spending function is applied to the monitoring plan for the Lung Health Study (Anthonisen, 1989, American Review of Respiratory Diseases 140, 871-872).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1420840

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  6 in total

1.  Longitudinal clinical trials with adaptive choice of follow-up time.

Authors:  Neal Jeffries; Nancy L Geller
Journal:  Biometrics       Date:  2015-03-27       Impact factor: 2.571

2.  Detecting treatment differences in group sequential longitudinal studies with covariate adjustment.

Authors:  Neal O Jeffries; James F Troendle; Nancy L Geller
Journal:  Biometrics       Date:  2017-12-18       Impact factor: 2.571

3.  Estimation of conditional power for cluster-randomized trials with interval-censored endpoints.

Authors:  Kaitlyn Cook; Rui Wang
Journal:  Biometrics       Date:  2020-09-12       Impact factor: 1.701

4.  More data, less information? Potential for nonmonotonic information growth using GEE.

Authors:  Abigail B Shoben; Kyle D Rudser; Scott S Emerson
Journal:  J Biopharm Stat       Date:  2016-04-06       Impact factor: 1.051

5.  Flexible stopping boundaries when changing primary endpoints after unblinded interim analyses.

Authors:  Liddy M Chen; Joseph G Ibrahim; Haitao Chu
Journal:  J Biopharm Stat       Date:  2014       Impact factor: 1.051

6.  Effect of esketamine on perioperative depressive symptoms in major surgery patients (PASSION II): study protocol for a randomised controlled trial.

Authors:  Yang Zhou; Bo Ma; Wanchen Sun; Juan Wang; Yuxuan Fu; Anxin Wang; Gang Wang; Ruquan Han
Journal:  BMJ Open       Date:  2022-04-26       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.